Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 5 IN PLASTIC CONTAINER versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 5 IN PLASTIC CONTAINER versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
MANNITOL 5% IN PLASTIC CONTAINER vs OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases the osmolarity of the glomerular filtrate, reducing tubular reabsorption of water and solutes. It also draws water from intracellular spaces into the extracellular fluid, reducing cerebral edema and intraocular pressure.
Increases plasma osmolality, drawing water from tissues into the bloodstream, thereby reducing intracranial pressure and cerebral edema.
50-100 g intravenously over 30-60 minutes for initial dose in acute renal failure or cerebral edema; maintenance dose 25-50 g every 6-8 hours based on serum osmolality and urine output.
Initial: 0.25–1 g/kg (25–100 mL of 10% solution) IV over 30–60 minutes. May repeat every 6–12 hours if needed. Typical adult dose: 50–100 g IV. Maximum: 2 g/kg per dose.
None Documented
None Documented
Terminal elimination half-life: 1–2 hours (adults with normal renal function); prolonged to 24–48 hours in severe renal impairment.
Terminal half-life approximately 1.5 hours in normal renal function; prolonged in renal impairment (up to 36 hours in anuria).
Renal: >90% as unchanged drug via glomerular filtration; negligible biliary or fecal elimination.
Primarily renal; >90% excreted unchanged in urine via glomerular filtration; <5% biliary/fecal.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic